CD4 and lung carcinoma: The deletion of HDAC2 induced the transition from M2 to M1‐like TAM, activated T‐cell activation‐related signaling pathways, reduced CD4+ T cells and increased CD8+ T‐cell infiltration, and inhibited the lung cancer progression.73